| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 63,155 | 64,753 | 72,216 | 68,207 | | Cost of Revenue | 50,925 | 53,141 | 57,558 | 57,955 | | | Gross Profit | 12,230 | 11,612 | 14,658 | 10,252 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,090 | 7,071 | 7,811 | 9,658 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,140 | 4,541 | 6,847 | 594 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (24) | 6 | (20) | 10 | | Earnings Before Interest And Taxes | 4,116 | 4,547 | 6,827 | 604 | | Interest Expense | 508 | 483 | 508 | 145 | | Income Before Tax | 3,608 | 4,064 | 6,319 | 459 | | Income Tax Expense | 505 | 1,457 | 2,506 | 210 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,103 | 2,607 | 3,813 | 249 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,103 | 2,607 | 3,813 | 249 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,103 | $2,607 | $3,813 | $249 |
|
1.41% Nasdaq 
Income Statement
